These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36057403)

  • 21. Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry.
    Guidetti P; Hoffman GE; Melendez-Ferro M; Albuquerque EX; Schwarcz R
    Glia; 2007 Jan; 55(1):78-92. PubMed ID: 17024659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases.
    Jauch D; Urbańska EM; Guidetti P; Bird ED; Vonsattel JP; Whetsell WO; Schwarcz R
    J Neurol Sci; 1995 May; 130(1):39-47. PubMed ID: 7650530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of three angiotensin-converting enzyme inhibitors on kynurenic acid production in rat kidney in vitro.
    Zakrocka I; Kocki T; Turski WA
    Pharmacol Rep; 2017 Jun; 69(3):536-541. PubMed ID: 28364692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Kynurenine Challenge Disrupts Sleep-Wake Architecture and Impairs Contextual Memory in Adult Rats.
    Pocivavsek A; Baratta AM; Mong JA; Viechweg SS
    Sleep; 2017 Nov; 40(11):. PubMed ID: 29029302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kynurenine Aminotransferases I, II and III Are Present in Saliva.
    Baran H; Kronsteiner C; Kepplinger B
    Neurosignals; 2020 Mar; 28(1):1-13. PubMed ID: 32153151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells.
    Walczak K; Dąbrowski W; Langner E; Zgrajka W; Piłat J; Kocki T; Rzeski W; Turski WA
    Scand J Gastroenterol; 2011 Jul; 46(7-8):903-12. PubMed ID: 21615226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perivascular brown adipocytes-derived kynurenic acid relaxes blood vessel via endothelium PI3K-Akt-eNOS pathway.
    Wang H; Li J; Wang Z; Tian Y; Li C; Jin F; Li J; Wang L
    Biomed Pharmacother; 2022 Jun; 150():113040. PubMed ID: 35658210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action.
    Chmiel-Perzyńska I; Perzyński A; Olajossy B; Gil-Kulik P; Kocki J; Urbańska EM
    J Diabetes Res; 2019; 2019():4957879. PubMed ID: 31737685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism.
    Navrotskaya V; Wnorowski A; Turski W; Oxenkrug G
    Neurotox Res; 2018 Aug; 34(2):324-331. PubMed ID: 29619629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous level of kynurenic acid and activities of kynurenine aminotransferases following transient global ischemia in the gerbil hippocampus.
    Luchowska E; Luchowski P; Sarnowska A; Wielosz M; Turski WA; Urbańska EM
    Pol J Pharmacol; 2003; 55(3):443-7. PubMed ID: 14506324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
    Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
    Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of tryptophan metabolism and distortion of cell signaling after oral exposure to ethanol and Kynurenic acid.
    Yang C; Liao C; Zhao J; Guan Q; Wang G; Han Q
    Gene; 2023 Feb; 852():147061. PubMed ID: 36423775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
    Baran H; Kepplinger B
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II.
    Kocki T; Luchowski P; Luchowska E; Wielosz M; Turski WA; Urbanska EM
    Neurosci Lett; 2003 Jul; 346(1-2):97-100. PubMed ID: 12850557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Acetylcysteine Inhibits Kynurenine Aminotransferase II.
    Blanco-Ayala T; Sathyasaikumar KV; Uys JD; Pérez-de-la-Cruz V; Pidugu LS; Schwarcz R
    Neuroscience; 2020 Sep; 444():160-169. PubMed ID: 32768617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantum mechanics/molecular mechanics (QM/MM) modeling of the irreversible transamination of L-kynurenine to kynurenic acid: the round dance of kynurenine aminotransferase II.
    Bellocchi D; Macchiarulo A; Carotti A; Pellicciari R
    Biochim Biophys Acta; 2009 Dec; 1794(12):1802-12. PubMed ID: 19715778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior.
    Potter MC; Elmer GI; Bergeron R; Albuquerque EX; Guidetti P; Wu HQ; Schwarcz R
    Neuropsychopharmacology; 2010 Jul; 35(8):1734-42. PubMed ID: 20336058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental diabetes mellitus type 1 increases hippocampal content of kynurenic acid in rats.
    Chmiel-Perzyńska I; Perzyński A; Urbańska EM
    Pharmacol Rep; 2014 Dec; 66(6):1134-9. PubMed ID: 25443746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling.
    Luchowska E; Kloc R; Olajossy B; Wnuk S; Wielosz M; Owe-Larsson B; Urbanska EM
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):519-29. PubMed ID: 19439240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.
    Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):209-217. PubMed ID: 30370429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.